Who Paid My Doc
John Laird
Cardiovascular Disease Sacramento, CA Medical Doctor
NPI 1144290636 CMS profile 97495
4860 Y St # 2820, Sacramento, CA 95817
General payments
$73,643
Research payments
$7,000
Ownership & investment interest
$8,040
Research they led as principal investigator
$136,480
Through program year 2025, John Laird of Sacramento, CA is reported in the CMS Open Payments database as having received $73,643 across 238 general payments and $7,000 in research payments paid to them. Separately, studies naming them as principal investigator received $136,480 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $8,040 across 2 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $32 | 1 | |
| 2024 | General | $529 | 4 | |
| 2023 | General | $800 | 13 | |
| 2022 | General | $2,064 | 51 | |
| 2021 | General | $2,703 | 50 | |
| 2020 | General | $16,254 | 33 | |
| 2019 | General | $51,261 | 86 | |
| 2019 | Research | $7,000 | 1 | |
| 2025 | Ownership | $4,020 | 1 | |
| 2023 | Ownership | $4,020 | 1 |
Beside peers
- John Laird
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to John Laird were reported at $32. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | John Laird | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $51,261 | $450 | $127–$1,392 | $163 |
| 2020 | $16,254 | $242 | $77–$751 | $114 |
| 2021 | $2,703 | $335 | $101–$1,037 | $132 |
| 2022 | $2,064 | $395 | $121–$1,211 | $149 |
| 2023 | $800 | $443 | $136–$1,283 | $160 |
| 2024 | $529 | $450 | $136–$1,323 | $164 |
| 2025 | $32 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 53 billing codesPaid by Medicare
$29,306
Medicare patients
233
Services billed
355
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 58% | |
| Heart failure | 42% | |
| Arthritis | 42% | |
| Diabetes | 40% | |
| Chronic kidney disease | 36% | |
| Atrial fibrillation | 35% | |
| COPD | 23% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
239 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in California
Ted Love
Cardiovascular Disease · Hillsborough, CA
Paul Kurth
Cardiovascular Disease · Santa Barbara, CA
Jason Rogers
Cardiovascular Disease · Sacramento, CA
Matthew Budoff
Cardiovascular Disease · Torrance, CA
Eric Topol
Cardiovascular Disease · La Jolla, CA
Cathleen Bairey-Merz
Cardiovascular Disease · Los Angeles, CA
Related records
Cardiovascular Disease in California
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.